Operating Expenses Summary of Wai Chun Bio-Technology Limited

Wai Chun Bio-Technology Limited's latest annual operating expenses in 2022 was 35.87 Million HKD , down -8.76% from previous year.
Wai Chun Bio-Technology Limited's latest quarterly operating expenses in 2023 Q4 was 10.93 Million HKD , up 102.33% from previous quarter.
Wai Chun Bio-Technology Limited reported a annual operating expenses of 39.31 Million HKD in annual operating expenses 2021, up 4.81% from previous year.
Wai Chun Bio-Technology Limited reported a annual operating expenses of 37.51 Million HKD in annual operating expenses 2020, up 13.28% from previous year.
Wai Chun Bio-Technology Limited reported a quarterly operating expenses of 5.4 Million HKD for 2023 Q3, down -68.62% from previous quarter.
Wai Chun Bio-Technology Limited reported a quarterly operating expenses of 17.22 Million HKD for 2023 Q2, up 102.79% from previous quarter.

Annual Operating Expenses Chart of Wai Chun Bio-Technology Limited (2022 - 2004)

Historical Annual Operating Expenses of Wai Chun Bio-Technology Limited (2022 - 2004)

Year	Operating Expenses	Operating Expenses Growth
2022	35.87 Million HKD	-8.76%
2021	39.31 Million HKD	4.81%
2020	37.51 Million HKD	13.28%
2019	33.11 Million HKD	-52.72%
2018	70.03 Million HKD	169.14%
2017	26.02 Million HKD	-45.84%
2016	48.04 Million HKD	147.33%
2015	19.42 Million HKD	-9.67%
2014	21.5 Million HKD	-33.51%
2013	32.34 Million HKD	-12.51%
2012	36.97 Million HKD	37.88%
2011	26.81 Million HKD	-40.0%
2010	44.68 Million HKD	57.02%
2009	28.45 Million HKD	-54.13%
2008	62.04 Million HKD	43.59%
2007	43.21 Million HKD	14.33%
2006	37.79 Million HKD	-41.14%
2005	64.21 Million HKD	48.59%
2004	43.21 Million HKD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2023 Q4	10.93 Million HKD	102.33%
2023 Q3	5.4 Million HKD	-68.62%
2023 Q2	17.22 Million HKD	102.79%
2023 Q1	8.49 Million HKD	-61.61%
2022 Q3	11.02 Million HKD	-51.8%
2022 Q4	22.12 Million HKD	100.72%
2022 FY	35.87 Million HKD	-8.76%
2022 Q2	22.86 Million HKD	0.0%
2021 Q3	8.17 Million HKD	-57.58%
2021 Q4	16.44 Million HKD	101.12%
2021 FY	39.31 Million HKD	4.81%
2021 Q1	9.79 Million HKD	-61.21%
2021 Q2	19.27 Million HKD	96.73%
2020 Q3	12.88 Million HKD	-8.15%
2020 Q1	6.83 Million HKD	-61.05%
2020 Q4	25.25 Million HKD	96.09%
2020 Q2	14.02 Million HKD	105.19%
2020 FY	37.51 Million HKD	13.28%
2019 Q2	17.85 Million HKD	106.41%
2019 Q3	8.42 Million HKD	-52.81%
2019 Q4	17.54 Million HKD	108.25%
2019 Q1	8.64 Million HKD	-66.79%
2019 FY	33.11 Million HKD	-52.72%
2018 Q1	7.51 Million HKD	-20.29%
2018 Q3	26.04 Million HKD	246.34%
2018 FY	70.03 Million HKD	169.14%
2018 Q4	26.04 Million HKD	0.0%
2018 Q2	7.51 Million HKD	0.0%
2017 Q4	9.43 Million HKD	0.0%
2017 Q3	9.43 Million HKD	87.42%
2017 Q2	5.03 Million HKD	0.0%
2017 FY	26.02 Million HKD	-45.84%
2017 Q1	5.03 Million HKD	-30.27%
2016 FY	48.04 Million HKD	147.33%
2016 Q3	7.21 Million HKD	-61.67%
2016 Q2	18.83 Million HKD	0.0%
2016 Q1	18.83 Million HKD	198.75%
2016 Q4	7.21 Million HKD	0.0%
2015 Q4	6.3 Million HKD	0.0%
2015 FY	19.42 Million HKD	-9.67%
2015 Q3	6.3 Million HKD	24.6%
2015 Q2	5.05 Million HKD	0.0%
2015 Q1	5.05 Million HKD	5.7%
2014 Q4	4.78 Million HKD	0.0%
2014 FY	21.5 Million HKD	-33.51%
2014 Q3	4.78 Million HKD	-3.33%
2014 Q2	4.95 Million HKD	0.0%
2014 Q1	4.95 Million HKD	-39.78%
2013 FY	32.34 Million HKD	-12.51%
2013 Q3	8.22 Million HKD	-2.36%
2013 Q4	8.22 Million HKD	0.0%
2013 Q1	8.42 Million HKD	4.13%
2013 Q2	8.42 Million HKD	0.0%
2012 Q2	9.24 Million HKD	0.0%
2012 Q3	9.24 Million HKD	0.0%
2012 Q1	9.24 Million HKD	0.0%
2012 FY	36.97 Million HKD	37.88%
2012 Q4	8.08 Million HKD	-12.51%
2011 Q4	9.24 Million HKD	37.88%
2011 FY	26.81 Million HKD	-40.0%
2011 Q1	6.7 Million HKD	0.0%
2011 Q2	6.7 Million HKD	0.0%
2011 Q3	6.7 Million HKD	0.0%
2010 Q3	11.17 Million HKD	0.0%
2010 FY	44.68 Million HKD	57.02%
2010 Q4	6.7 Million HKD	-40.0%
2010 Q2	11.17 Million HKD	0.0%
2010 Q1	11.17 Million HKD	0.0%
2009 FY	28.45 Million HKD	-54.13%
2009 Q4	11.17 Million HKD	57.02%
2009 Q3	7.11 Million HKD	0.0%
2009 Q2	7.11 Million HKD	0.0%
2009 Q1	7.11 Million HKD	0.0%
2008 Q1	15.51 Million HKD	0.0%
2008 FY	62.04 Million HKD	43.59%
2008 Q4	7.11 Million HKD	-54.13%
2008 Q3	15.51 Million HKD	0.0%
2008 Q2	15.51 Million HKD	0.0%
2007 Q2	10.8 Million HKD	0.0%
2007 Q1	10.8 Million HKD	0.0%
2007 FY	43.21 Million HKD	14.33%
2007 Q3	10.8 Million HKD	0.0%
2007 Q4	15.51 Million HKD	43.59%
2006 Q1	9.44 Million HKD	0.0%
2006 Q2	9.44 Million HKD	0.0%
2006 Q3	9.44 Million HKD	0.0%
2006 Q4	10.8 Million HKD	14.33%
2006 FY	37.79 Million HKD	-41.14%
2005 Q2	16.05 Million HKD	0.0%
2005 Q1	16.05 Million HKD	0.0%
2005 FY	64.21 Million HKD	48.59%
2005 Q4	9.44 Million HKD	-41.14%
2005 Q3	16.05 Million HKD	0.0%
2004 FY	43.21 Million HKD	0.0%
2004 Q2	10.8 Million HKD	0.0%
2004 Q1	10.8 Million HKD	0.0%
2004 Q4	16.05 Million HKD	48.59%
2004 Q3	10.8 Million HKD	0.0%
2003 Q4	10.8 Million HKD	0.0%

Peer Operating Expenses Comparison of Wai Chun Bio-Technology Limited

Name	Operating Expenses	Operating Expenses Difference
Lee & Man Chemical Company Limited	588.88 Million HKD	93.908%

Global Stocks Search

Wai Chun Bio-Technology Limited (0660.HK)

Operating Expenses Summary of Wai Chun Bio-Technology Limited

Annual Operating Expenses Chart of Wai Chun Bio-Technology Limited (2022 - 2004)

Historical Annual Operating Expenses of Wai Chun Bio-Technology Limited (2022 - 2004)

Peer Operating Expenses Comparison of Wai Chun Bio-Technology Limited